Skip to main content

Table 2 Laboratory characteristics on admission

From: Clinical characteristics, organ failure, inflammatory markers and prediction of mortality in patients with community acquired bloodstream infection

  Proportion Case fatality Unadjusted odds ratios (95%CI) for case fatality P values
Neutropenia (< 1500 cell/mm3) (%) 28/388 (7.2%) 22 (78.6%) 11.682 (4.588–29.746) < 0.001
Hemoglobin< 80 g/L 31/389 (8.0%) 11 (35.5%) 1.459 (0.675–3.156) 0.337
RIFLE criteria
 No renal dysfunction 283/386 (73.3%) 56 (19.8%) 1  
 RIFLE-risk 50/386 (13.0%) 16 (32.0%) 1.908 (0.984–3.699) 0.056
 RIFLE-failure 52/386 (13.5%) 35 (67.3%) 8.346 (4.361–15.971) < 0.001
Hypoalbuminemia (albumin ≤30 g/L) 72/245 (29.4%) 39 (54.2%) 3.263 (1.839–5.789) < 0.001
Aspartate Aminotransferase (AST) ≥ 2 ULN 153/379 (40.4%) 65 (42.5%) 3.435 (2.150–5.487) < 0.001
Alanine aminotransferase (ALT) ≥ 2 ULN 109/378 (28.8%) 45 (41.3%) 2.449 (1.520–3.947) < 0.001
Platelet < 100 × 103/mm3 169/389 (43.4%) 70 (41.4%) 3.282 (2.068–5.208) < 0.001
Procalcitonin
 PCT ≤ 0.005 ng/mL (%) 6/239 (2.5%) 2 (33.3%) 1  
 PCT > 0.005–2 ng/mL (%) 83/239 (34.7%) 11 (13.3%) 0.306 (0.050–1.871) 0.2
 PCT > 2–10 ng/mL (%) 59/239 (24.7%) 20 (33.9%) 1.026 (0.173–6.087) 0.978
 PCT > 10–100 ng/mL (%) 69/239 (28.9%) 29 (42.0%) 1.45 (0.249–8.457) 0.68
 PCT > 100 ng/mL (%) 22/239 (9.2%) 14 (63.6%) 3.5 (0.520–23.559) 0.198
C-reactive protein (CRP) (median, IQR) (mg/L)
 CRP less than 5 mg/L (%) 14/341 (4.1%) 4 (28.6%) 1  
 CRP from 5.01 to 20 mg/L (%) 26/341 (7.6%) 4 (15.4%) 0.455 (0.094–2.195) 0.326
 CRP from 20.001 to 100 mg/L (%) 112/341 (32.8%) 29 (25.9%) 0.873 (0.254–3.001) 0.83
 CRP more than 100 mg/L (%) 189/341 (55.4%) 56 (29.6%) 1.053 (0.317–3.498) 0.933
  1. ULN upper limit of normal; RIFLE Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease